insulin analog, aspart (niacinamide) 100 UNT/ML Injectable Solution

RxCUI
2730174
RxNorm name
insulin analog, aspart (niacinamide) 100 UNT/ML Injectable Solution
Display name
insulin analog, aspart (niacinamide) 100 UNT/ML Injectable Solution
Full name
insulin analog, aspart (niacinamide) 100 UNT/ML Injectable Solution
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:06

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
208751Fiaspinsulin aspart351(a)Rx2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
FiaspINSULIN ASPART INJECTIONNovo Nordisk834e7efc-393f-4c55-9125-628562a8a5cf2023-06-21Warnings, Adverse reactionsExact identifier
rxcui: 2730174

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
834e7efc-393f-4c55-9125-628562a8a5cfinsulin aspart (niacinamide) 100 UNT/ML Injectable Solution [PSN] · Niacinamide insulin aspart, human 100 UNT/ML Injectable Solution [SCD] · insulin analog, aspart (niacinamide) 100 UNT/ML Injectable Solution [SY]318These highlights do not include all the information needed to use FIASP safely and effectively. See full prescribing information for FIASP. FIASP ® (insulin aspart) injection, for subcutaneous or intravenous use Initial U.S. Approval: 200020230621